Anti-Hu CD319 FITC
CD319 is a homophilic type I transmembrane protein with two intracellular immunoreceptor tyrosine-based switch motives (ITSMs) . It is expressed by cytotoxic T cells, activated B cells and plasma cells, NK cells, and mature dendritic cells. CD319 triggers NK cell-mediated cytotoxicity. Ligation of CD319 can induce proliferation, cell adhesion, cytokine secretion, and cytotoxicity of T cells and NK cells.
Product Specifications
Certification
RUO
Reactivity
Human
Immunogen
Recombinant extracellular domain of human CD319 (204 aa) fused with Fc part of human IgG1
Target Antigen
CD319
Clone
162
Applications
FC (QC tested)
Format
FITC
Buffer
Stabilizing phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
References & Citations
*Chan WK, Kang S, Youssef Y, Glankler EN, Barrett ER, Carter AM, Ahmed EH, Prasad A, Chen L, Zhang J, Benson DM Jr, Caligiuri MA, Yu J: A CS1-NKG2D bispecific antibody collectively activates cytolytic immune cells against multiple myeloma. Cancer Immunol Res. 2018 Jul;6 (7) :776-787. , URL: https://pubmed.ncbi.nlm.nih.gov/29769244/
Storage Conditions
Store at 2-8°C. Protect from prolonged exposure to light. Do not freeze.
Specificity
The mouse monoclonal antibody 162 recognizes an extracellular epitope of human CD319, a transmembrane glycoprotein expressed by cytotoxic T cells, activated B cells, NK cells, and mature dendritic cells.
Applications Notes
6
Isotype
Mouse IgG2b
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PC1003774-01 250 mg
Ethyl 7-bromo-1-cyclopropyl-8- (difluoromethoxy) -4-oxo-1,4-dihydroquinoline-3-carboxylate
Sign In for Pricing
View Details PC1003774-02 1 g
Ethyl 7-bromo-1-cyclopropyl-8- (difluoromethoxy) -4-oxo-1,4-dihydroquinoline-3-carboxylate
Sign In for Pricing
View Details PC1003774-03 5 g
Ethyl 7-bromo-1-cyclopropyl-8- (difluoromethoxy) -4-oxo-1,4-dihydroquinoline-3-carboxylate
Sign In for Pricing
View Details 